VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LGND
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LGNDLigand Pharmaceuticals Incorporated
$298.71$6.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLGNDQuarterly Balance Sheet

Ligand Pharmaceuticals Incorporated (LGND) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Ligand Pharmaceuticals Incorporated (LGND) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

LGND Balance Sheet

Quarterly statement

LGND Balance Sheet

Ligand Pharmaceuticals Incorporated (LGND) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets608.23M1.46B865.41M832.27M753.92M352.94M309.32M331.56M309.39M312.26M368.91M237.43M253.99M276.71M328.19M263.6M220.43M243.78M276.07M464.75M
Cash & Short-Term Investments447.39M1.36B779.4M733.52M664.52M255.3M208.9M256.17M219.64M226.93M310.59M170.31M190.5M219.04M282.67M211.87M121.41M147.94M204M341.11M
Cash Only55.96M1.01B115.08M174.93M139.38M67.67M47.99M72.31M63.62M18.14M50.09M22.95M19.27M28.45M282.67M45.01M4.12M5.28M14.99M19.52M
Short-Term Investments391.44M351.06M664.33M558.59M525.15M187.63M160.91M183.86M156.02M208.79M260.5M147.35M171.23M190.6M0166.86M117.29M142.66M189.01M321.59M
Accounts Receivable107.52M69.92M54.8M61.05M58.1M42.12M42.83M42.45M42.13M37.48M28.43M39.31M36M27.99M29.19M35.04M65.95M63.27M41.8M91.65M
Days Sales Outstanding103.6589.1100.7991.8539.9281.1584.6590.8870.6872.2299.51123.2989.5798.6865.72171.77100.3895.37164.45103.05
Inventory14.51M10.26M13.27M9.13M11.9M12.89M11.81M14.11M13.44M14.47M21.34M23.97M25.39M26.91M14.01M13.29M22.33M24.77M25.61M27.33M
Days Inventory Outstanding429.99333.1485.61-37.2245.94386.65240.62446.77102.76-106.31186.251.36K690.31.12K330.5775.81153.08185.47506.98231.54
Other Current Assets38.81M19.17M17.95M28.58M19.4M40.04M42.97M16.9M30.87M27.26M7.31M2.66M2.1M2.77M2.33M2.27M10.75M7.8M4.66M4.67M
Total Non-Current Assets1.63B728.76M666.69M728.37M722.85M595.66M596.12M610.22M645.48M554.15M544.96M549.79M515.23M481.39M482.88M499.07M830.17M832.5M829.12M832.84M
Property, Plant & Equipment24.22M6.44M10.28M10.79M11.07M11.62M10.49M24.81M25.19M25.46M24.38M25.06M25.98M26.54M15.61M27.49M46.55M39.74M55.99M32.6M
Fixed Asset Turnover5.14x7.62x4.91x5.46x10.17x4.31x2.57x1.71x2.05x1.67x1.25x1.10x1.25x1.25x2.04x0.73x1.37x1.05x0.82x1.79x
Goodwill207.86M101.54M101.54M101.54M101.54M101.54M101.54M105.25M105.25M105.25M105.25M103.37M103.77M105.67M439.59M105.67M698.23M709.57M181.21M105.67M
Intangible Assets302.04M209.24M410.88M422.31M233.53M250.13M258.39M266.65M274.9M283.16M291.42M299.61M321.44M336.16M10.43M352.64M10.19M10.27M549.83M386.8M
Long-Term Investments142.92M156.87M132.81M183.58M42M204.46M199.23M195.93M212.4M93.66M112.68M111.61M47.08M003M0000
Other Non-Current Assets848.07M217.54M2.71M1.79M325.18M27.07M25.92M17.51M27.65M46.43M11.22M9.92M8.43M4.5M16.38M1.74M39.7M37.27M6.44M272.03M
Total Assets2.24B2.19B1.53B1.56B1.48B948.6M905.43M941.77M954.87M866.4M913.87M787.22M769.23M758.11M811.08M762.67M1.05B1.08B1.11B1.3B
Asset Turnover0.04x0.03x0.03x0.04x0.10x0.05x0.05x0.05x0.06x0.05x0.04x0.04x0.04x0.03x0.06x0.03x0.06x0.05x0.03x0.06x
Asset Growth %51.51%130.43%69.21%65.71%54.66%9.49%-0.92%19.63%24.13%14.29%12.67%3.22%-26.78%-29.56%-26.61%-41.22%-17.51%-14.33%-14.67%-4.75%
Total Current Liabilities500.57M46.74M40.67M37.45M30.54M64.73M58.68M37.11M24.77M18.57M17.82M16.78M15.73M29.39M98.93M98.81M135.24M167.85M42.58M41.66M
Accounts Payable4.09M9.4M5.26M3.24M27.76M8.58M5.37M5.23M4.69M1.79M1.89M2.43M2.48M9.58M6.13M5.31M15.89M19.15M6.97M8.4M
Days Payables Outstanding234.34207.67184.38-54.8767.36218.3498.36160.9623.88-10.9417.76135.51159.15428.47138.5245.11113.8996.16147.2460.02
Short-Term Debt448.31M000000000000076.79M76.69M76.6M114.97M00
Deferred Revenue (Current)0621K621K621K135K732K722K1.9M1.77M1.82M1.85M1.84M621K621K257K976K9.55M10.58M10.5M654K
Other Current Liabilities43.61M544K4.13M6.81M268K39.67M28.88M-3.2M3.96M2.83M2.03M4.94M3.81M2.79M13.31M6.26M14.88M12.14M5.14M22.57M
Current Ratio1.22x31.18x21.28x22.23x24.69x5.45x5.27x8.93x12.49x16.82x20.70x14.15x16.15x9.42x3.32x2.67x1.63x1.45x6.48x11.15x
Quick Ratio1.19x30.96x20.95x21.98x24.30x5.25x5.07x8.55x11.95x16.04x19.51x12.72x14.54x8.50x3.18x2.53x1.46x1.30x5.88x10.50x
Cash Conversion Cycle299.3214.52402.02109.5118.5249.46226.91376.69149.56-23.152681.35K620.72785.68257.76202.47139.57184.68524.19274.58
Total Non-Current Liabilities775.13M1.17B494.12M505.98M496.06M55.34M51.22M74.22M88.92M72.64M89.53M69.52M85.6M63.83M65.83M66.37M99.07M106.07M269.41M434.77M
Long-Term Debt679.91M1.13B446.9M446.19M445.49M0000000000000176.54M320.72M
Capital Lease Obligations21.43M3.78M3.99M4.2M4.42M4.63M3.56M5.82M6.27M6.42M5.19M5.75M5.83M10.99M11.18M10.34M34.89M27.09M16.76M2.26M
Deferred Tax Liabilities22.4M21.65M22.61M52.61M22.67M32.25M29.38M32.52M46.4M30.13M50.61M31.62M32.59M27.66M30.01M30.61M29.83M42.67M39.48M30.86M
Other Non-Current Liabilities51.39M19.6M20.61M2.97M23.48M18.47M18.27M35.88M33.74M18.59M16.97M17M47.19M25.17M24.64M25.38M28.8M28.89M36.64M80.94M
Total Liabilities1.28B1.22B534.78M543.42M526.6M120.08M109.9M111.33M113.69M91.21M107.35M86.3M101.33M93.21M164.76M165.18M234.31M273.92M311.99M476.43M
Total Debt1.15B1.13B451.98M451.49M451M5.74M4.45M7.11M7.36M7.58M6.19M6.17M6.33M11.67M88.68M87.75M113.89M144.61M195.2M324.39M
Net Debt1.1B124.75M336.9M276.56M311.62M-61.93M-43.54M-65.2M-56.26M-10.56M-43.9M-16.79M-12.95M-16.77M-193.99M42.74M109.77M139.33M180.21M304.86M
Debt / Equity1.20x1.17x0.45x0.44x0.47x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.02x0.14x0.15x0.14x0.18x0.25x0.40x
Debt / EBITDA-67.32x17.67x15.22x7.14x0.34x--0.61x-0.53x1.11x0.54x1.55x3.73x3.76x4.41x6.65x12.37x12.63x
Net Debt / EBITDA-7.42x13.17x9.32x4.93x-3.65x---4.64x--3.74x-3.02x-1.11x-2.23x-8.16x1.83x4.25x6.41x11.42x11.87x
Interest Coverage-36.79x-12.89x31.81x155.10x10.73x-56.88x-43.39x-7.55x-50.57x805.59x131.51x-12143.00x12.17x59.19x234.04x38.21x20.77x-10.59x-0.57x
Total Equity961.76M967.52M997.32M1.02B950.17M828.53M795.53M830.44M841.18M775.2M806.52M700.91M667.9M664.89M646.32M597.49M816.3M802.37M793.19M821.16M
Equity Growth %1.22%16.78%25.37%22.49%12.96%6.88%-1.36%18.48%25.94%16.59%24.79%17.31%-18.18%-17.13%-18.52%-27.24%0.52%2.02%6.35%15.73%
Book Value per Share48.1844.3150.1648.1247.1141.5841.4543.7745.6743.0044.5139.6538.4337.5035.9635.3847.6547.5747.1549.07
Total Shareholders' Equity961.76M967.52M997.32M1.02B950.17M828.53M795.53M830.44M841.18M775.2M806.52M700.91M667.9M664.89M646.32M597.49M816.3M802.37M793.19M821.16M
Common Stock20K20K20K20K20K20K20K20K19K19K18K18K18K17K17K17K17K17K17K17K
Retained Earnings554.77M583.25M594.74M608.09M578.22M461.38M456.53M498.98M530.07M537.24M589.15M503.02M484.83M495.1M492.81M450.86M468.35M467.94M468.84M449.09M
Treasury Stock00000000000000000000
Accumulated OCI3.44M4.48M5.39M8.46M9.32M8.49M-1.56M-5.94M1.75M-935K-910K-817K-944K-967K-935K-984K-1.06M-1.07M-1.03M-917K
Minority Interest00000000000000000000